Wed, February 20, 2019
[ Wed, Feb 20th 2019 ]: WOPRAI
George Bahamondes Downgraded (ABR) to Hold on, Feb 20th, 2019
Tue, February 19, 2019
[ Tue, Feb 19th 2019 ]: WOPRAI
Paul Coster Downgraded (TPIC) to Hold and Held Target at $35 on, Feb 19th, 2019
[ Tue, Feb 19th 2019 ]: WOPRAI
Michael Baker Downgraded (ULTA) to Hold and Increased Target to $311 on, Feb 19th, 2019
[ Tue, Feb 19th 2019 ]: WOPRAI
Philip Cusick Downgraded (UNIT) to Sell and Decreased Target to $16 on, Feb 19th, 2019
[ Tue, Feb 19th 2019 ]: WOPRAI
Frank Louthan Downgraded (UNIT) to Hold on, Feb 19th, 2019
[ Tue, Feb 19th 2019 ]: WOPRAI
Gregory Williams Downgraded (UNIT) to Hold on, Feb 19th, 2019
[ Tue, Feb 19th 2019 ]: WOPRAI
Allison Landry Maintained (XPO) at Buy with Decreased Target to $70 on, Feb 19th, 2019
[ Tue, Feb 19th 2019 ]: WOPRAI
Stephanie Benjamin Maintained (XPO) at Strong Buy with Decreased Target to $65 on, Feb 19th, 2019
[ Tue, Feb 19th 2019 ]: WOPRAI
Ravi Shanker Downgraded (XPO) to Hold and Decreased Target to $71 on, Feb 19th, 2019
[ Tue, Feb 19th 2019 ]: WOPRAI
Tobey Sommer Downgraded (CCRN) to Hold on, Feb 19th, 2019
Fri, February 15, 2019
[ Fri, Feb 15th 2019 ]: WOPRAI
Myles Walton Downgraded (B) to Hold and Decreased Target to $65 on, Feb 15th, 2019
[ Fri, Feb 15th 2019 ]: WOPRAI
Jacob Kilstein Downgraded (AIG) to Hold on, Feb 15th, 2019
[ Fri, Feb 15th 2019 ]: WOPRAI
Michael Schmidt Upgraded (AGIO) to Buy and Held Target at $80 on, Feb 15th, 2019
[ Fri, Feb 15th 2019 ]: WOPRAI
Derrick Wood Upgraded (WDAY) to Buy and Increased Target to $225 on, Feb 15th, 2019
[ Fri, Feb 15th 2019 ]: WOPRAI
Nehal Chokshi Upgraded (SMCI) to Strong Buy and Held Target at $3.8 on, Feb 15th, 2019
[ Fri, Feb 15th 2019 ]: WOPRAI
Haendel St. Juste Downgraded (SPG) to Hold on, Feb 15th, 2019
[ Fri, Feb 15th 2019 ]: WOPRAI
Lee Krowl Downgraded (TRUE) to Hold and Decreased Target to $9.5 on, Feb 15th, 2019
[ Fri, Feb 15th 2019 ]: WOPRAI
Shweta Khajuria Downgraded (TRUE) to Hold on, Feb 15th, 2019
[ Fri, Feb 15th 2019 ]: WOPRAI
Robert Drbul Downgraded (TPX) to Hold on, Feb 15th, 2019
Thu, February 14, 2019
[ Thu, Feb 14th 2019 ]: WOPRAI
Wendy Nicholson Maintained (TAP) at Strong Buy with Decreased Target to $69 on, Feb 14th, 2019
[ Thu, Feb 14th 2019 ]: WOPRAI
Vamil Divan Maintained (TEVA) at Hold with Decreased Target to $20 on, Feb 14th, 2019
[ Thu, Feb 14th 2019 ]: WOPRAI
Elliot Wilbur Upgraded (TEVA) to Buy on, Feb 14th, 2019
[ Thu, Feb 14th 2019 ]: WOPRAI
Jeff Van Sinderen Initiated (CDXC) at Strong Buy and Held Target at $7 on, Feb 14th, 2019
[ Thu, Feb 14th 2019 ]: WOPRAI
Paul Bieber Maintained (YELP) at Buy with Increased Target to $59 on, Feb 14th, 2019
[ Thu, Feb 14th 2019 ]: WOPRAI
Brian Nowak Maintained (YELP) at Sell with Increased Target to $31 on, Feb 14th, 2019
[ Thu, Feb 14th 2019 ]: WOPRAI
Mark May Downgraded (YELP) to Hold on, Feb 14th, 2019
[ Thu, Feb 14th 2019 ]: WOPRAI
Alex Rygiel Maintained (TMHC) at Hold with Increased Target to $21 on, Feb 14th, 2019
[ Thu, Feb 14th 2019 ]: WOPRAI
Ryan Nash Upgraded (SYF) to Strong Buy on, Feb 14th, 2019
Wed, February 13, 2019
[ Wed, Feb 13th 2019 ]: WOPRAI
Christopher York Maintained (ARCC) at Buy with Increased Target to $20 on, Feb 13th, 2019
[ Wed, Feb 13th 2019 ]: WOPRAI
Mark Delaney Upgraded (APTV) to Strong Buy on, Feb 13th, 2019
[ Wed, Feb 13th 2019 ]: WOPRAI
Jeffrey Silber Maintained (BFAM) at Hold with Increased Target to $122 on, Feb 13th, 2019
[ Wed, Feb 13th 2019 ]: WOPRAI
Glenn Chin Initiated (AN) at Hold on, Feb 13th, 2019
[ Wed, Feb 13th 2019 ]: WOPRAI
Mark Mahaney Maintained (AKAM) at Hold with Decreased Target to $76 on, Feb 13th, 2019
[ Wed, Feb 13th 2019 ]: WOPRAI
James Fish Maintained (AKAM) at Buy with Increased Target to $85 on, Feb 13th, 2019
[ Wed, Feb 13th 2019 ]: WOPRAI
Sameet Sinha Maintained (AKAM) at Strong Buy with Decreased Target to $102 on, Feb 13th, 2019
[ Wed, Feb 13th 2019 ]: WOPRAI
Keith Weiss Maintained (AKAM) at Buy with Increased Target to $80 on, Feb 13th, 2019
[ Wed, Feb 13th 2019 ]: WOPRAI
Brandon Nispel Maintained (AKAM) at Buy with Increased Target to $76 on, Feb 13th, 2019
Tue, February 12, 2019
[ Tue, Feb 12th 2019 ]: WOPRAI
Gerrick Johnson Downgraded (TTWO) to Sell on, Feb 12th, 2019
[ Tue, Feb 12th 2019 ]: WOPRAI
Chad Bennett Downgraded (VRNS) to Hold on, Feb 12th, 2019
[ Tue, Feb 12th 2019 ]: WOPRAI
Yun Kim Downgraded (VRNS) to Hold on, Feb 12th, 2019
[ Tue, Feb 12th 2019 ]: WOPRAI
Greg McDowell Downgraded (VRNS) to Hold on, Feb 12th, 2019
[ Tue, Feb 12th 2019 ]: WOPRAI
Gur Talpaz Downgraded (VRNS) to Hold on, Feb 12th, 2019
[ Tue, Feb 12th 2019 ]: WOPRAI
Brandon Nispel Maintained (AMT) at Buy with Increased Target to $180 on, Feb 12th, 2019
[ Tue, Feb 12th 2019 ]: WOPRAI
Dan Leonard Maintained (A) at Strong Buy with Increased Target to $85 on, Feb 12th, 2019
[ Tue, Feb 12th 2019 ]: WOPRAI
Stephen Byrd Maintained (AEE) at Hold with Increased Target to $69 on, Feb 12th, 2019
Mon, February 11, 2019
[ Mon, Feb 11th 2019 ]: WOPRAI
Jeffrey Silber Maintained (TBI) at Hold with Decreased Target to $24 on, Feb 11th, 2019
[ Mon, Feb 11th 2019 ]: WOPRAI
Ronald Epstein Upgraded (TGI) to Strong Buy and Increased Target to $35 on, Feb 11th, 2019
[ Mon, Feb 11th 2019 ]: WOPRAI
Sarah Akers Maintained (SRE) at Buy with Increased Target to $64 on, Feb 11th, 2019

Vamil Divan Maintained (TEVA) at Hold with Decreased Target to $20 on, Feb 14th, 2019

Vamil Divan of Credit Suisse, Maintained "Teva Pharmaceutical Industries Limited" (TEVA) at Hold with Decreased Target from $26 to $20 on, Feb 14th, 2019.

Vamil has made no other calls on TEVA in the last 4 months.



There are 3 other peers that have a rating on TEVA. Out of the 3 peers that are also analyzing TEVA, 1 agrees with Vamil's Rating of Hold. Following is the relevant analyst calls for the last 4 months

  • David Amsellem of "Piper Sandler" Upgraded from Sell to Hold and Increased Target to $16 on, Wednesday, January 23rd, 2019


These are the ratings of the 2 analyists that currently disagree with Vamil

  • Jason Gerberry of "B of A Securities" Upgraded from Sell to Strong Buy on, Thursday, January 3rd, 2019
  • David Risinger of "Morgan Stanley" Upgraded from Hold to Buy and Held Target at $27 on, Monday, November 5th, 2018